育龄期高水平生殖激素对大鼠围绝经期及绝经后血压的影响
Effects of high exposure of endogenous reproductive hormones on perimenopausal and postmenopausal blood pressure in rats

DOI: 10.6040/j.issn.1671-7554.0.2017.219

Keywords: 雌激素,血压,育龄期,绝经期,孕激素,血管紧张素Ⅱ-1型受体,
Progesterone,Blood pressure,Postmenopausal phase,Estrogen,Reproductive phase,Angiotensin II type-1 receptor

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Brunt VE, Miner JA, Kaplan PF, et al. Short-term administration of progesterone and estradiol independently alter carotid-vasomotor, but not carotid-cardiac, baroreflex function in young women[J]. Am J Physiol Heart Circ Physiol, 2013, 305(7): H1041-1049.
[2]	Ricchiuti V, Lian CG, Oestreicher EM, et al. Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats[J]. J Endocrinol, 2009, 200(1): 75-84.
[3]	Chidambaram M, Duncan JA, Lai VS, et al. Variation in the renin angiotensin system throughout the normal menstrual cycle[J]. J Am Soc Nephrol, 2002, 13(2): 446-452.
[4]	Szmuilowicz ED, Adler GK, Williams JS, et al. Relationship between aldosterone and progesterone in the human menstrual cycle[J]. J Clin Endocrinol Metab, 2006, 91(10): 3981-3987.
[5]	Robitaille C, Dai S, Waters C, et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality[J]. CMAJ, 2012, 184(1): E49-56.
[6]	Wenner MM, Stachenfeld NS. Blood pressure and water regulation: understanding sex hormone effects within and between men and women[J]. J Physiol, 2012, 590(23): 5949-5961.
[7]	周宜, 陈钢, 夏丽娜, 等. 外源雌孕激素建立人工性周期大鼠模型的探索[J]. 中药药理与临床, 2007, 23(1): 76-77. ZHOU Yi, CHEN Gang, XIA Lina, et al. An exploration method of establishing an rat artificial estrous cycle from exogenous estrogen and progesterone[J]. Pharmacology and Clinics of Chinese Materia Medica, 2007, 23(1): 76-77.
[8]	Rapsomaniki E, Timmis A, George J, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people[J]. Lancet, 2014, 383(9932): 1899-1911.
[9]	Barton M, Meyer MR. Postmenopausal hypertension: mechanisms and therapy[J]. Hypertension, 2009, 54(1): 11-18.
[10]	Zhou Y, Zhou X, Guo X, et al. Prevalence and risk factors of hypertension among pre- and post-menopausal women: a cross-sectional study in a rural area of northeast China[J]. Maturitas, 2015, 80(3): 282-287.
[11]	Taddei S. Blood pressure through aging and menopause[J]. Climacteric, 2009, 12(Suppl 1): 36-40.
[12]	Son MK, Lim NK, Lim JY, et al. Difference in blood pressure between early and late menopausal transition was significant in healthy Korean women[J]. BMC Womens Health, 2015, 15: 64-71. doi: 10.1186/s12905-015-0219-9
[13]	Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Womens Health Initiative randomized controlled trial[J]. JAMA, 2002, 288(3): 321-333.
[14]	Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up(HERS II)[J]. JAMA, 2002, 288(1): 49-57.
[15]	Issa Z, Seely EW, Rahme M, et al. Effects of hormone therapy on blood pressure[J]. Menopause, 2015, 22(4): 456-468.
[16]	Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C)method[J]. Methods, 2001, 25(4): 402-408.
[17]	Oneda B, Cardoso CG., Jr, Forjaz CL, et al. Effects of estrogen therapy and aerobic training on sympathetic activity and hemodynamics in healthy postmenopausal women: a double-blind randomized trial[J]. Menopause, 2014, 21(4): 369-375.
[18]	Subramanian M, Balasubramanian P, Garver H, et al. Chronic estradiol-17beta exposure increases superoxide production in the rostral ventrolateral medulla and causes hypertension: reversal by resveratrol[J]. Am J Physiol Regul Integr Comp Physiol, 2011, 300(6): R1560-1568.
[19]	Zimmerman MA, Hutson DD, Trimmer EH, et al. Long- but not short-term estradiol treatment induces renal damage in midlife ovariectomized Long-Evans rats[J]. Am J Physiol Renal Physiol, 2017, 312(2): F305- F311.
[20]	Mompeon A, Lazaro-Franco M, Bueno-Beti C, et al. Estradiol, acting through ERalpha, induces endothelial non-classic renin-angiotensin system increasing angiotensin 1-7 production[J]. Mol Cell Endocrinol, 2016, 422(c): 1-8. doi: 10.1016/j.mce.2015.11.004
[21]	Meng X, Dai X, Liao TD, et al. Dose-dependent toxic effects of high-dose estrogen on renal and cardiac injury in surgically postmenopausal mice[J]. Life Sci, 2011, 88(3-4): 178-186.
[22]	Ryan J, Stanczyk FZ, Dennerstein L, et al. Hormone levels and cognitive function in postmenopausal midlife women[J]. Neurobiol Aging, 2012, 33(7): 1138-1147.
[23]	Wharton W, Gleason CE, Olson SR, et al. Neurobiological underpinnings of the estrogen-mood relationship[J]. Curr Psychiatry Rev, 2012, 8(3): 247-256.
[24]	Subramanian M, Hahn-Townsend C, Clark KA, et al. Chronic estrogen exposure affects gene expression in the rostral ventrolateral medulla of young and aging rats: Possible role in hypertension[J]. Brain Res, 2015, 1627(19): 134-142.
[25]	Kafami M, Hosseini M, Niazmand S, et al. Interaction of central Angiotensin II and estrogen on systolic blood pressure in female DOCA-salt treated rats[J]. Adv Biomed Res, 2016, 5: 78-85. doi: 10.4103/2277-9175.180990
[26]	Ozdemir Kumral ZN, Kolgazi M, Ustunova S, et al. Estrogen receptor agonists alleviate cardiac and renal oxidative injury in rats with renovascular hypertension[J]. Clin Exp Hypertens, 2016, 38(6): 500-509.
[27]	Murase T, Hattori T, Ohtake M, et al. Effects of estrogen on cardiovascular injury in ovariectomized female DahlS.Z-Lepr(fa)/Lepr(fa)rats as a new animal model of metabolic syndrome[J]. Hypertension, 2012, 59(3): 694-704.
[28]	Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Womens Health Initiative randomized controlled trial[J]. JAMA, 2004, 291(14): 1701-1712.
[29]	Boardman HM, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women[J]. Cochrane Database Syst Rev, 2015, 10(3): 22-29.
[30]	Reslan OM, Yin Z, do Nascimento GR, et al. Subtype-specific estrogen receptor-mediated vasodilator activity in the cephalic, thoracic, and abdominal vasculature of female rat[J]. J Cardiovasc Pharmacol, 2013, 62(1): 26-40.
[31]	Koganti S, Snyder R, Thekkumkara T. Pharmacologic effects of 2-methoxyestradiol on angiotensin type 1 receptor down-regulation in rat liver epithelial and aortic smooth muscle cells[J]. Gend Med, 2012, 9(2): 76-93.
[32]	Zhan E, Keimig T, Xu J, et al. Dose-dependent cardiac effect of oestrogen replacement in mice post-myocardial infarction[J]. Exp Physiol, 2008, 93(8): 982-993.

Full-Text